|
|
Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). Michelle M Tabb, Vladyslav Kholodovych, Felix Grün, Changcheng Zhou, William J Welsh, and Bruce Blumberg Environ Health Perspect. 2004 February; 112(2): 163–169. PMCID: PMC1241825
Is Cited by the Following Articles in this Archive: Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes Mark D. Miller, Kevin M. Crofton, Deborah C. Rice, and R. Thomas Zoeller Environ Health Perspect. 2009 July; 117(7): 1033–1041. Published online 2009 February 12. doi: 10.1289/ehp.0800247.PMCID: PMC2717126 The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism
Changcheng Zhou, Suman Verma, and Bruce Blumberg Nucl Recept Signal. 2009; 7: e001. Published online 2009 January 16. doi: 10.1621/nrs.07001.PMCID: PMC2646121 Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells Suman Verma, Michelle M Tabb, and Bruce Blumberg BMC Cancer. 2009; 9: 3. Published online 2009 January 5. doi: 10.1186/1471-2407-9-3.PMCID: PMC2631587 PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics Bin Zhang, Wen Xie, and Mathew D Krasowski Pharmacogenomics. Author manuscript; available in PMC 2009 September 1.PMCID: PMC2593625 Published in final edited form as: Pharmacogenomics. 2008 November; 9(11): 1695–1709. doi: 10.2217/14622416.9.11.1695. INTRINSIC DISORDER IN NUCLEAR HORMONE RECEPTORS Matthew D. Krasowski, Erica J. Reschly, and Sean Ekins J Proteome Res. Author manuscript; available in PMC 2009 October 1.PMCID: PMC2700763 Published in final edited form as: J Proteome Res. 2008 October; 7(10): 4359–4372. Published online 2008 July 24. doi: 10.1021/pr8003024. Activation of Steroid and Xenobiotic Receptor (SXR, NR1I2) and Its Orthologs in Laboratory, Toxicologic, and Genome Model Species Matthew R. Milnes, Adriana Garcia, Emily Grossman, Felix Grün, Jason Shiotsugu, Michelle M. Tabb, Yukio Kawashima, Yoshinao Katsu, Hajime Watanabe, Taisen Iguchi, and Bruce Blumberg Environ Health Perspect. 2008 July; 116(7): 880–885. Published online 2008 March 12. doi: 10.1289/ehp.10853.PMCID: PMC2453155 HUMAN PREGNANE X RECEPTOR ANTAGONISTS AND AGONISTS DEFINE MOLECULAR REQUIREMENTS FOR DIFFERENT BINDING SITES Sean Ekins, Cheng Chang, Sridhar Mani, Matthew D. Krasowski, Erica J. Reschly, Manisha Iyer, Vladyslav Kholodovych, Ni Ai, William J. Welsh, Michael Sinz, Peter W. Swaan, Rachana Patel, and Kenneth Bachmann Mol Pharmacol. Author manuscript; available in PMC 2008 September 1.PMCID: PMC2254307 Published in final edited form as: Mol Pharmacol. 2007 September; 72(3): 592–603. Published online 2007 June 18. doi: 10.1124/mol.107.038398. Endocrine Disrupting Contaminants—Beyond the Dogma Louis J. Guillette, Jr. Environ Health Perspect. 2006 April; 114(S-1): 9–12. Published online 2005 October 21. doi: 10.1289/ehp.8045.PMCID: PMC1874172 Thyroid-Hormone–Disrupting Chemicals: Evidence for Dose-Dependent Additivity or Synergism Kevin M. Crofton, Elena S. Craft, Joan M. Hedge, Chris Gennings, Jane E. Simmons, Richard A. Carchman, W. Hans Carter, Jr, and Michael J. DeVito Environ Health Perspect. 2005 November; 113(11): 1549–1554. Published online 2005 July 21. doi: 10.1289/ehp.8195.PMCID: PMC1310917 Study on Failures to Disclose Conflicts of Interest in Environmental Health Perspectives Merrill Goozner Environ Health Perspect. 2004 October; 112(14): A794–A795. PMCID: PMC1247594
|